Skip to content

Management of Chronic Anal Fissure through Ayurveda and Yoga.

Efficacy and safety of Jatyadi Ghrita and Ashwini Mudra in Chronic Anal Fissure: An open-label prospective randomized controlled pilot study. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084678
Enrollment
66
Registered
2025-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Topical application of Jatyadi Ghrita, Ashwini Mudra and topical nifedipine 0.3% and lidocaine 1.5% cream: Patients in group A will be treated with topical Jatyadi Ghrita ointment twice

Sponsors

All India Institute of Medical Sciences Bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Willing to participate. 2. The age should be 16 to 60 years 3. Gender will be both male and female 4. Patients with a diagnosis of chronic anal fissure who had symptoms for more than 6 weeks. 5. Patients whose symptoms are not resolved by stool softeners, high fiber diet, warm sitz bath, etc. 6. A physical examination will show an anal ulcer with indurated edges and/or skin tag. 7. The VAS score should be between 3 to 7.

Exclusion criteria

Exclusion criteria: 1. History of reaction to topical agents. 2. Patients whose symptoms resolved within 6 weeks by stool softeners, high fiber diet, and warm sitz bath. 3. Patient with multiple anal fissures. 4. Patients suffering from severe anemia, carcinoma, chrons disease, ulcerative colitis, diabetes mellitus, hypertension, and HIV. 5. Pregnant women 6. Tuberculous ulcers and leukemic ulcers should be excluded. 7. Patient with perianal abscess, anal fistula, and third and fourth-degree hemorrhoids. 8. Chronic anal fissure patients with severe pain (VAS more than 7) and excessive bleeding per anum should be excluded.

Design outcomes

Primary

MeasureTime frame
Change in REALISE score at baseline, after 2 weeks, 4 weeks, and 8 weeks of treatmentTimepoint: Baseline, 2 weeks, 4 weeks and 8 weeks of treatment.

Secondary

MeasureTime frame
Healing period of chronic anal fissure. Adverse events during treatment. Timepoint: Baseline, 2 weeks, 4 weeks and 8 weeks of treatment.

Countries

India

Contacts

Public ContactAjit Kumar Pradhan

All India Institute of Medical Sciences Bhubaneswar

ayush_ajit@aiimsbhubaneswar.edu.in9337832305

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026